Uniwersyteckie Centrum Kliniczne Klinika Onkoligii i Radioterapii
Welcome,         Profile    Billing    Logout  
 0 Trials 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Szutowicz, Ewa
MOUNTAINEER-03, NCT05253651 / 2021-002672-40: A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

Recruiting
3
400
Europe, Canada, Japan, US, RoW
tucatinib, TUKYSA, ONT-380, ARRY-380, PF-07265792, trastuzumab, Herceptin, bevacizumab, Avastin, cetuximab, Erbitux, oxaliplatin, leucovorin, levoleucovorin, fluorouracil
Seagen Inc., Merck Sharp & Dohme LLC
Colorectal Neoplasms
08/25
04/28
NCT04915404 / 2019-004015-31: Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme (WHO Grade IV)

Terminated
1/2
5
Europe
Berubicin Hydrochloride
WPD Pharmaceuticals Sp. z o.o., Worldwide Clinical Trials, National Center for Research and Development, Poland
Recurrent Glioblastoma Multiforme
12/23
12/23
Badania, Koordynator
NCT04915404 / 2019-004015-31: Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme (WHO Grade IV)

Terminated
1/2
5
Europe
Berubicin Hydrochloride
WPD Pharmaceuticals Sp. z o.o., Worldwide Clinical Trials, National Center for Research and Development, Poland
Recurrent Glioblastoma Multiforme
12/23
12/23

Download Options